SID 26681509
CAS No. 958772-66-2
SID 26681509 ( —— )
产品货号. M26442 CAS No. 958772-66-2
SID 26681509 是一种选择性、可逆且竞争性的人组织蛋白酶 L 抑制剂(IC50 为 56 nM)。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥1416 | 有现货 |
|
| 10MG | ¥2204 | 有现货 |
|
| 25MG | ¥3720 | 有现货 |
|
| 50MG | ¥5282 | 有现货 |
|
| 100MG | ¥7155 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥1682 | 有现货 |
|
生物学信息
-
产品名称SID 26681509
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述SID 26681509 是一种选择性、可逆且竞争性的人组织蛋白酶 L 抑制剂(IC50 为 56 nM)。
-
产品描述SID 26681509 is a selective, reversible and competitive human cathepsin L inhibitor (IC50 of 56 nM).(In Vitro):After a 4 hr preincubation with cathepsin L, SID 26681509 becomes more potent(IC50 : 1.0 nM). SID 26681509 is determined to be a slow-binding and slowly reversible competitive inhibitor. Through a transient kinetic analysis for single-step reversibility, inhibition rate constants are kon = 24,000 M-1s-1 and koff = 2.2 × 10-5 s-1 (Ki = 0.89 nM). Molecular docking studies are undertaken using the experimentally-derived X-ray crystal structure of papain/CLIK-148. SID 26681509 inhibits papain and cathepsins B, K, S, and V with IC50 values determined after one hour ranging from 618 nM to 8.442 μM.(In Vivo):survival in murine models of sepsis significantly improved SID 26681509 by and reduces liver damage following warm liver ischemia/reperfusion (I/R) models.
-
体外实验After a 4 hr preincubation with cathepsin L, SID 26681509 becomes more potent, demonstrating an IC50 of 1.0 nM. SID 26681509 is determined to be a slow-binding and slowly reversible competitive inhibitor. Through a transient kinetic analysis for single-step reversibility, inhibition rate constants are kon = 24,000 M-1s-1 and koff = 2.2 × 10-5 s-1 (Ki = 0.89 nM). Molecular docking studies are undertaken using the experimentally-derived X-ray crystal structure of papain/CLIK-148. SID 26681509 inhibits papain and cathepsins B, K, S, and V with IC50 values determined after one hour ranging from 618 nM to 8.442 μM. SID 26681509 shows no inhibitory activity against the serine protease cathepsin G. SID 26681509 inhibits cathepsin V activity with an IC50 value of 0.5 μM. SID 26681509 (1-30 μM) blocks high-mobility group box 1 (HMGB1)-induced TNF-α production dose dependently without altering cell viability.
-
体内实验SID 26681509 treatment significantly improves survival in murine models of sepsis and reduces liver damage following warm liver ischemia/reperfusion (I/R) models.
-
同义词——
-
通路Proteasome/Ubiquitin
-
靶点Cysteine Protease
-
受体Hormone-sensitive lipase (HSL)
-
研究领域——
-
适应症——
化学信息
-
CAS Number958772-66-2
-
分子量539.65
-
分子式C27H33N5O5S
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 50 mg/mL (92.65 mM)
-
SMILESCCc1ccccc1NC(=O)CSC(=O)NNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)OC(C)(C)C
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Ebdrup, Soren, et al. PHARMACEUTICAL USE OF BORONIC ACIDS AND ESTERS THEREOF. US7037905.
产品手册
关联产品
-
(1S,2R)-Alicapistat
(1S,2R)-Alicapistat ((1S,2R)-ABT-957) 是一种具有口服活性的人钙激活中性蛋白酶 (calpains 1 和 2) 的选择性抑制剂,可能用于阿尔茨海默病 (AD) 的研究。 Alicapistat 可减轻羰基还原的代谢倾向,对 calpain 1 的 IC50 为 395 nM。
-
CA 074
CA-074是组织蛋白酶B (cathepsin B) 的有效抑制剂, Ki 值为2 to 5 nM。
-
MK-0674
MK-0674 是一种有效、可口服、选择性的 cathepsin K 抑制剂,IC50 值为 0.4 nM,对其选择性分别是 Cat B,Cat F,Cat L 和 Cat S 的 1156,1465,11857 和 243 倍。
021-51111890
购物车()
sales@molnova.cn

